{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:26:39Z","timestamp":1764332799272},"reference-count":98,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4889","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T05:13:50Z","timestamp":1569993230000},"source":"Crossref","is-referenced-by-count":3,"title":["Cellular and molecular alterations induced by low\u2011dose fisetin in human chronic myeloid leukemia cells"],"prefix":"10.3892","author":[{"given":"Anna","family":"Klimaszewska\u2011Wi\u015bniewska","sequence":"first","affiliation":[{"name":"Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Grzanka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Czajkowska","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ha\u0142as\u2011Wi\u015bniewska","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Dur\u015blewicz","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Antosik","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Grzanka","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Gagat","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 85\u2011092 Bydgoszcz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"key20200713190104_b1-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ijc.22419","article-title":"Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties","volume":"120","author":"Thomasset","year":"2007","journal-title":"Int J Cancer"},{"key":"key20200713190104_b2-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/mnfr.200700326","article-title":"Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways","volume":"52","author":"Ramos","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"key20200713190104_b3-ijo-55-06-1261","first-page":"282570","article-title":"Chemotherapy and dietary phytochemical agents","volume":"2012","author":"Sak","year":"2012","journal-title":"Chemother Res Pract"},{"key":"key20200713190104_b4-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20200713190104_b5-ijo-55-06-1261","first-page":"89","article-title":"Bioactive flavonoid fisetin-a molecule of pharmacological interest","volume":"2","author":"Jash","year":"2014","journal-title":"J Org Biomol Chem"},{"key":"key20200713190104_b6-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/or.2017.5676","article-title":"Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor","volume":"38","author":"Liu","year":"2017","journal-title":"Oncol Rep"},{"key":"key20200713190104_b7-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1158\/0008-5472.CAN-08-0240","article-title":"A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice","volume":"68","author":"Khan","year":"2008","journal-title":"Cancer Res"},{"key":"key20200713190104_b8-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/ars.2012.4901","article-title":"Fisetin: A dietary antioxidant for health promotion","volume":"19","author":"Khan","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"key20200713190104_b9-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.semcancer.2016.04.003","article-title":"Exploring the molecular targets of dietary flavonoid fisetin in cancer","volume":"40-41","author":"Syed","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"key20200713190104_b10-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2015.07.030","article-title":"Dietary flavonoid fisetin binds to \u03b2-tubulin and disrupts microtubule dynamics in prostate cancer cells","volume":"367","author":"Mukhtar","year":"2015","journal-title":"Cancer Lett"},{"key":"key20200713190104_b11-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/carcin\/bgq115","article-title":"Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells","volume":"31","author":"Suh","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20200713190104_b12-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41419-019-1366-y","article-title":"Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress-and mitochondrial stress-dependent pathways","volume":"10","author":"Jia","year":"2019","journal-title":"Cell Death Dis"},{"key":"key20200713190104_b13-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/carcin\/bgp101","article-title":"Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint","volume":"30","author":"Salmela","year":"2009","journal-title":"Carcinogenesis"},{"key":"key20200713190104_b14-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"9615","DOI":"10.1007\/s13277-016-4864-x","article-title":"Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway","volume":"37","author":"Kang","year":"2016","journal-title":"Tumor Biol"},{"key":"key20200713190104_b15-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/tox.22396","article-title":"Fisetin-induced apoptosis of human oral cancer SCC-4 cells through reactive oxygen species production, endoplasmic reticulum stress, caspase-, and mitochondria-dependent signaling pathways","volume":"32","author":"Su","year":"2017","journal-title":"Environ Toxicol"},{"key":"key20200713190104_b16-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/carcin\/bgn078","article-title":"Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells","volume":"29","author":"Khan","year":"2008","journal-title":"Carcinogenesis"},{"key":"key20200713190104_b17-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0006-2952(01)00876-0","article-title":"Wogonin and fisetin induce apoptosis in human promyelo-leukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endo-nuclease","volume":"63","author":"Lee","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key20200713190104_b18-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00204-002-0346-6","article-title":"Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1","volume":"76","author":"Chen","year":"2002","journal-title":"Arch Toxicol"},{"key":"key20200713190104_b19-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2012.01.008","article-title":"Activation of reactive oxygen species\/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells","volume":"319","author":"Jang","year":"2012","journal-title":"Cancer Lett"},{"key":"key20200713190104_b20-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/carcin\/bgv045","article-title":"Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter","volume":"36","author":"Kim","year":"2015","journal-title":"Carcinogenesis"},{"key":"key20200713190104_b21-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1124\/mol.107.034512","article-title":"Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation","volume":"71","author":"Sung","year":"2007","journal-title":"Mol Pharmacol"},{"key":"key20200713190104_b22-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1742-7843.2010.00613.x","article-title":"Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells","volume":"108","author":"Li","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key20200713190104_b23-ijo-55-06-1261","first-page":"481","article-title":"Nitric oxide is the key mediator of death induced by fisetin in human acute monocytic leukemia cells","volume":"5","author":"Ash","year":"2015","journal-title":"Am J Cancer Res"},{"key":"key20200713190104_b24-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1007\/s13277-015-4118-3","article-title":"Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling","volume":"37","author":"Adan","year":"2016","journal-title":"Tumor Biol"},{"key":"key20200713190104_b25-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1007\/s13277-015-3597-6","article-title":"The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks","volume":"36","author":"Adan","year":"2015","journal-title":"Tumor Biol"},{"key":"key20200713190104_b26-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.abb.2014.06.034","article-title":"Involvement of ER stress and activation of apoptotic pathways in fisetin induced cytotoxicity in human melanoma","volume":"563","author":"Syed","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"key20200713190104_b27-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/jcb.25490","article-title":"The dietary flavonoid fisetin causes cell cycle arrest, caspase-dependent apoptosis, and enhanced cytotoxicity of chemotherapeutic drugs in triple-negative breast cancer cells","volume":"117","author":"Smith","year":"2016","journal-title":"J Cell Biochem"},{"key":"key20200713190104_b28-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/ijc.24628","article-title":"Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB","volume":"125","author":"Murtaza","year":"2009","journal-title":"Int J Cancer"},{"key":"key20200713190104_b29-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00204-011-0754-6","article-title":"Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1\/2-mediated activation of caspase-8-\/caspase-3-dependent pathway","volume":"86","author":"Ying","year":"2012","journal-title":"Arch Toxicol"},{"key":"key20200713190104_b30-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"G1060","DOI":"10.1152\/ajpgi.90490.2008","article-title":"Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin","volume":"296","author":"Lim","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20200713190104_b31-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/carcin\/bgn269","article-title":"A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt\/EGFR\/NF-kappaB-signaling pathways","volume":"30","author":"Suh","year":"2009","journal-title":"Carcinogenesis"},{"key":"key20200713190104_b32-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/exd.12181","article-title":"Fisetin inhibits growth, induces G2\/M arrest and apoptosis of human epidermoid carcinoma A431 cells: Role of mitochondrial membrane potential disruption and consequent caspases activation","volume":"22","author":"Pal","year":"2013","journal-title":"Exp Dermatol"},{"key":"key20200713190104_b33-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.biopha.2016.08.035","article-title":"Fisetin inhibits laryngeal carcinoma through regulation of AKT\/NF-\u03baB\/mTOR and ERK1\/2 signaling pathways","volume":"83","author":"Zhang","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"key20200713190104_b34-ijo-55-06-1261","first-page":"5678","article-title":"Fisetin suppresses malignant proliferation in human oral squamous cell carcinoma through inhibition of Met\/Src signaling pathways","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res"},{"key":"key20200713190104_b35-ijo-55-06-1261","first-page":"1103","article-title":"Fisetin induces apoptosis of HSC3 human oral cancer cells through endoplasmic reticulum stress and dysfunction of mitochondria-mediated signaling pathways","volume":"31","author":"Shih","year":"2017","journal-title":"In Vivo"},{"key":"key20200713190104_b36-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1107\/S0108270113029545","article-title":"A 1:2 cocrystal of genistein with isonicotinamide: Crystal structure and Hirshfeld surface analysis","volume":"69","author":"Sowa","year":"2013","journal-title":"Acta Crystallogr C"},{"key":"key20200713190104_b37-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1039\/C4CE01713G","article-title":"Improving solubility of fisetin by cocrystallization","volume":"16","author":"Sowa","year":"2014","journal-title":"Cryst Eng Comm"},{"key":"key20200713190104_b38-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/10717544.2016.1245366","article-title":"Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HP\u03b2CD in polymeric nanoparticles","volume":"24","author":"Kadari","year":"2017","journal-title":"Drug Deliv"},{"key":"key20200713190104_b39-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ijpharm.2012.02.025","article-title":"Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice","volume":"427","author":"Ragelle","year":"2012","journal-title":"Int J Pharm"},{"key":"key20200713190104_b40-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-13-0043","article-title":"A proposal regarding reporting of in vitro testing results","volume":"19","author":"Smith","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20200713190104_b41-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12935-016-0288-3","article-title":"Paclitaxel and the dietary flavonoid fisetin: A synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells","volume":"16","author":"Klimaszewska-Wisniewska","year":"2016","journal-title":"Cancer Cell Int"},{"key":"key20200713190104_b42-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"E661","DOI":"10.3390\/ijms19030661","article-title":"Evaluation of anti-metastatic potential of the combination of fisetin with paclitaxel on A549 non-small cell lung cancer cells","volume":"19","author":"Klimaszewska-Wi\u015bniewska","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20200713190104_b43-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1535-7163.MCT-10-0606","article-title":"Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors","volume":"10","author":"Tripathi","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20200713190104_b44-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/ijc.26178","article-title":"Dual inhibition of phosphatidylinositol 3-kinase\/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin","volume":"130","author":"Khan","year":"2012","journal-title":"Int J Cancer"},{"key":"key20200713190104_b45-ijo-55-06-1261","doi-asserted-by":"crossref","first-page":"46028","DOI":"10.18632\/oncotarget.10016","article-title":"Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo","volume":"19","author":"Atashrazm","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713190104_b46-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"330","DOI":"10.18869\/acadpub.ibj.21.5.330","article-title":"Synergistic effects of arsenic trioxide and radiation: Triggering the intrinsic pathway of apoptosis","volume":"21","author":"Moloudi","year":"2017","journal-title":"Iran Biomed J"},{"key":"key20200713190104_b47-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.toxrep.2014.08.016","article-title":"Cellular uptake of quercetin and luteolin and their effects on monoamine oxidase-A in human neuroblastoma SH-SY5Y cells","volume":"1","author":"Bandaruk","year":"2014","journal-title":"Toxicol Rep"},{"key":"key20200713190104_b48-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/jf802378q","article-title":"Metabolism and pharmacokinetics of 3,3\u2032,4\u2032,7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites","volume":"57","author":"Shia","year":"2009","journal-title":"J Agric Food Chem"},{"key":"key20200713190104_b49-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"key20200713190104_b50-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and comput-erized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"key20200713190104_b51-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1080\/10428190802353591","article-title":"Preclinical versus clinical drug combination studies","volume":"49","author":"Chou","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20200713190104_b52-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/ijmm.2013.1357","article-title":"Effect of L-homocysteine on endothelial cell-cell junctions following F-actin stabilization through tropomyosin-1 overexpression","volume":"32","author":"Gagat","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20200713190104_b53-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713190104_b54-ijo-55-06-1261","first-page":"377","article-title":"Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: Possible involvement of p38 MAP kinase","volume":"35","author":"Shim","year":"2011","journal-title":"J Biochem Mol Biol"},{"key":"key20200713190104_b55-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"e104985","DOI":"10.1371\/journal.pone.0104985","article-title":"Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells","volume":"9","author":"Song","year":"2014","journal-title":"PLoS One"},{"key":"key20200713190104_b56-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/jnci\/91.9.772","article-title":"Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations","volume":"91","author":"Zhu","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"key20200713190104_b57-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1182\/blood-2015-06-641043","article-title":"Is there a best TKI for chronic phase CML?","volume":"126","author":"Larson","year":"2015","journal-title":"Blood"},{"issue":"Suppl 2","key":"key20200713190104_b58-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.3109\/10428190903383427","article-title":"Advances in treatment of chronic myelogenous leukemia new treatment options with tyrosine kinase inhibitors","volume":"50","author":"Santos","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"key20200713190104_b59-ijo-55-06-1261","doi-asserted-by":"crossref","first-page":"21674","DOI":"10.18632\/oncotarget.15535","article-title":"Genistein inhibits the growth and regulates the migration and invasion abilities of melanoma cells via the FAK\/paxillin and MAPK pathways","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713190104_b60-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"288","DOI":"10.7150\/jca.20499","article-title":"Genistein promotes proliferation of human cervical cancer cells through estrogen receptor-mediated PI3K\/Akt-NF-\u03baB pathway","volume":"9","author":"Chen","year":"2018","journal-title":"J Cancer"},{"key":"key20200713190104_b61-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.fct.2004.06.001","article-title":"Biphasic effect of daidzein on cell growth of human colon cancer cells","volume":"42","author":"Guo","year":"2004","journal-title":"Food Chem Toxicol"},{"key":"key20200713190104_b62-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/cdd.2017.47","article-title":"Killers creating new life: Caspases drive apoptosis-induced proliferation in tissue repair and disease","volume":"24","author":"Fogarty","year":"2017","journal-title":"Cell Death Differ"},{"key":"key20200713190104_b63-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/embor.2012.217","article-title":"Caspase signalling in the absence of apoptosis drives JNK-dependent invasion","volume":"14","author":"Rudrapatna","year":"2013","journal-title":"EMBO Rep"},{"key":"key20200713190104_b64-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"a008797","DOI":"10.1101\/cshperspect.a008797","article-title":"The role of apoptosis-induced proliferation for regeneration and cancer","volume":"4","author":"Ryoo","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20200713190104_b65-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1158\/1541-7786.MCR-07-0343","article-title":"Basal caspase activity promotes migration and invasiveness in glioblastomacells","volume":"5","author":"Gdynia","year":"2007","journal-title":"Mol Cancer Res"},{"key":"key20200713190104_b66-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"9121","DOI":"10.1158\/0008-5472.CAN-04-4344","article-title":"Cross talk between apoptosis and invasion signaling in cancer cells through caspase-3 activation","volume":"65","author":"Mukai","year":"2005","journal-title":"Cancer Res"},{"key":"key20200713190104_b67-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/embor.2012.224","article-title":"Death takes a holiday-non-apoptotic role for caspases in cell migration and invasion","volume":"14","author":"Portela","year":"2013","journal-title":"EMBO Rep"},{"key":"key20200713190104_b68-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"ra13","DOI":"10.1126\/scisignal.2000634","article-title":"Apoptotic cells activate the 'phoenix rising' pathway to promote wound healing and tissue regeneration","volume":"3","author":"Li","year":"2010","journal-title":"Sci Signal"},{"key":"key20200713190104_b69-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nm.2385","article-title":"Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy","volume":"17","author":"Huang","year":"2011","journal-title":"Nat Med"},{"key":"key20200713190104_b70-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/jid.2014.18","article-title":"Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy","volume":"134","author":"Donato","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key20200713190104_b71-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.molonc.2014.07.024","article-title":"Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase C\u03b4 activation in pancreatic ductal adenocarcinoma","volume":"9","author":"Cheng","year":"2015","journal-title":"Mol Oncol"},{"key":"key20200713190104_b72-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1158\/1078-0432.CCR-18-3001","article-title":"The caspase-3\/PKC\u03b4\/Akt\/VEGF-A signaling pathway mediates tumor repopulation during radiotherapy","volume":"25","author":"Cheng","year":"2019","journal-title":"Clin Cancer Res"},{"key":"key20200713190104_b73-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11626-007-9072-y","article-title":"Comparison of enzymically gluc-uronidated flavonoids with flavonoid aglycones in an in vitro cellular model of oxidative stress protection","volume":"44","author":"Stevenson","year":"2008","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"key20200713190104_b74-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mnfr.201500692","article-title":"Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides","volume":"60","author":"Zeng","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"key20200713190104_b75-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15226\/csroa.2015.00112","article-title":"In vitro cytotoxic activity of flavonoids on human ovarian cancer cell lines","volume":"2","author":"Sak","year":"2015","journal-title":"Cancer Sci Res"},{"key":"key20200713190104_b76-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1158\/0008-5472.CAN-14-0067","article-title":"Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner","volume":"74","author":"Volk-Draper","year":"2014","journal-title":"Cancer Res"},{"key":"key20200713190104_b77-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.1158\/0008-5472.CAN-11-0627","article-title":"Chemotherapy enhances metastasis formation via VEGFR-1-expressing endothelial cells","volume":"71","author":"Daenen","year":"2011","journal-title":"Cancer Res"},{"key":"key20200713190104_b78-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.leukres.2013.10.005","article-title":"Enhanced adhesion\/migration and induction of Pyk2 expression in K562 cells following imatinib exposure","volume":"37","author":"Ovcharenko","year":"2013","journal-title":"Leuk Res"},{"key":"key20200713190104_b79-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1476-4598-11-16","article-title":"RhoA: A therapeutic target for chronic myeloid leukemia","volume":"11","author":"Molli","year":"2012","journal-title":"Mol Cancer"},{"key":"key20200713190104_b80-ijo-55-06-1261","first-page":"6290","article-title":"MicroRNA-186 regulates cell malignancy by targeting ROCK1 in chronic myeloid leukemia","volume":"10","author":"Qi","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200713190104_b81-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: An updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann Med"},{"key":"key20200713190104_b82-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"E2396","DOI":"10.3390\/ijms19082396","article-title":"Biological aspects of mTOR in leukemia","volume":"19","author":"Mirabilii","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20200713190104_b83-ijo-55-06-1261","first-page":"3783","article-title":"The role of CD44 in epithelial-mesenchymal transition and cancer development","volume":"8","author":"Xu","year":"2015","journal-title":"Onco Targets Ther"},{"key":"key20200713190104_b84-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1475-2867-13-117","article-title":"CD44 targets Wnt\/\u03b2-catenin pathway to mediate the proliferation of K562 cells","volume":"13","author":"Chang","year":"2013","journal-title":"Cancer Cell Int"},{"key":"key20200713190104_b85-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jcma.2015.05.002","article-title":"Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy","volume":"78","author":"Chou","year":"2015","journal-title":"J Chinese Med Assoc"},{"key":"key20200713190104_b86-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12929-018-0440-6","article-title":"Emerging roles of epithelial-mesenchymal transition in hematological malignancies","volume":"25","author":"Chen","year":"2018","journal-title":"J Biomed Sci"},{"key":"key20200713190104_b87-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1878-0261.12085","article-title":"EMT- and MET-related processes in nonepithelial tumors: Importance for disease progression, prognosis, and therapeutic opportunities","volume":"11","author":"Kahlert","year":"2017","journal-title":"Mol Oncol"},{"key":"key20200713190104_b88-ijo-55-06-1261","doi-asserted-by":"crossref","first-page":"20977","DOI":"10.18632\/oncotarget.4007","article-title":"TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713190104_b89-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1182\/blood-2009-11-254680","article-title":"Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia","volume":"117","author":"Cosset","year":"2011","journal-title":"Blood"},{"key":"key20200713190104_b90-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.7150\/jca.19633","article-title":"Ectopic expression of Snail and Twist in Ph+ Leukemia cells upregulates CD44 expression and alters their differentiation potential","volume":"8","author":"Kidan","year":"2017","journal-title":"J Cancer"},{"key":"key20200713190104_b91-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00280-010-1505-8","article-title":"Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice","volume":"68","author":"Touil","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2 Suppl","key":"key20200713190104_b92-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1053\/shem.2002.33612","article-title":"Recent advances in Philadelphia chromosome-positive malignancies: The potential role of arsenic trioxide","volume":"39","author":"O'Dwyer","year":"2002","journal-title":"Semin Hematol"},{"issue":"Suppl 1","key":"key20200713190104_b93-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1634\/theoncologist.7-suppl_1-30","article-title":"Multifaceted approach to the treatment of bcrabl-positive leukemias","volume":"7","author":"O'Dwyer","year":"2002","journal-title":"Oncologist"},{"key":"key20200713190104_b94-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.febslet.2006.12.016","article-title":"Involvement of a Rho-ROCK-JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells","volume":"581","author":"Potin","year":"2007","journal-title":"FEBS Lett"},{"key":"key20200713190104_b95-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/sj.leu.2404735","article-title":"Arsenic trioxide and proteasome inhibitor bortezomib synergis-tically induce apoptosis in leukemic cells: The role of protein kinase Cdelta","volume":"27","author":"Yan","year":"2007","journal-title":"Leukemia"},{"key":"key20200713190104_b96-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/ijc.28427","article-title":"Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha","volume":"134","author":"El Eit","year":"2014","journal-title":"Int J Cancer"},{"key":"key20200713190104_b97-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3892\/mmr.2014.2333","article-title":"Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinibmesylate through Bcr\/Abl-dependent mechanisms","volume":"10","author":"Xu","year":"2014","journal-title":"Mol Med Rep"},{"key":"key20200713190104_b98-ijo-55-06-1261","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0301-472X(02)00836-6","article-title":"In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia","volume":"30","author":"La Ros\u00e9e","year":"2002","journal-title":"Exp Hematol"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:06:25Z","timestamp":1594667185000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":98,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4889","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]}}}